Arctigenin disrupts NLRP3 inflammasome assembly in colonic macrophages via downregulating fatty acid oxidation to prevent colitis-associated cancer

Abate, 2019, Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 Cancer Groups, 1990 to 2017: a systematic analysis for the global burden of disease study, JAMA Oncol Bray, 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA A Cancer J. Clin., 68, 394, 10.3322/caac.21492 Cox, 2020, Effects of low-FODMAP diet on symptoms,fecal microbiome, and markers of inflammation in patients with quiescent inflammatory bowel disease in a randomized trial, Gastroenterology, 158, 176, 10.1053/j.gastro.2019.09.024 Keum, 2019, Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies, Nat. Rev. Gastroenterol. Hepatol., 16, 713, 10.1038/s41575-019-0189-8 Terzić, 2010, Inflammation and colon cancer, Gastroenterology, 138, 2101, 10.1053/j.gastro.2010.01.058 Fumery, 2017, Incidence, risk factors, and outcomes of colorectal cancer in patients with ulcerative colitis with low-grade dysplasia: a systematic review and meta-analysis, Clin. Gastroenterol. Hepatol., 15, 665, 10.1016/j.cgh.2016.11.025 Guo, 2015, Inflammasomes: mechanism of action, role in disease, and therapeutics, Nat. Med., 21, 677, 10.1038/nm.3893 Zaki, 2011, The Nlrp3 inflammasome: contributions to intestinal homeostasis, Trends Immunol., 32, 171, 10.1016/j.it.2011.02.002 Voronov, 2015, IL-1 in colon inflammation, colon carcinogenesis and invasiveness of colon cancer, Cancer Microenvironment, 8, 187, 10.1007/s12307-015-0177-7 Apte, 2006, The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions, Canc. Metastasis Rev., 25, 387, 10.1007/s10555-006-9004-4 Zaki, 2010, The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis, Immunity, 32, 379, 10.1016/j.immuni.2010.03.003 Bader, 2018, Macrophage depletion using clodronate liposomes decreases tumorigenesis and alters gut microbiota in the AOM/DSS mouse model of colon cancer, Am. J. Physiol. Gastrointest. Liver Physiol., 314, G22, 10.1152/ajpgi.00229.2017 Seo, 2015, Distinct commensals induce interleukin-1β via NLRP3 inflammasome in inflammatory monocytes to promote intestinal inflammation in response to injury, Immunity, 42, 744, 10.1016/j.immuni.2015.03.004 Spalinger, 2018, PTPN2 regulates inflammasome activation and controls onset of intestinal inflammation and colon cancer, Cell Rep., 22, 1835, 10.1016/j.celrep.2018.01.052 Wu, 2015, Arctigenin exerts anti-colitis efficacy through inhibiting the differentiation of Th1 and Th17 cells via an mTORC1-dependent pathway, Biochem. Pharmacol., 96, 323, 10.1016/j.bcp.2015.06.008 Chen, 2013, (-)-Arctigenin as a lead compound for anticancer agent, Nat. Prod. Res., 27, 2251, 10.1080/14786419.2013.821120 Wang, 2017, Arctigenin inhibits prostate tumor cell growth in vitro and in vivo, Clinical Nutrition Experimental, 13, 1, 10.1016/j.yclnex.2017.04.001 Kim, 2010, Arctigenin blocks the unfolded protein response and shows therapeutic antitumor activity, J. Cell. Physiol., 224, 33 Fujioka, 2018, Change in plasma lactate concentration during arctigenin administration in a phase I clinical trial in patients with gemcitabine-refractory pancreatic cancer, PloS One, 13, 10.1371/journal.pone.0198219 Awale, 2006, Identification of arctigenin as an antitumor agent having the ability to eliminate the tolerance of cancer cells to nutrient starvation, Canc. Res., 66, 1751, 10.1158/0008-5472.CAN-05-3143 Parang, 2016, AOM/DSS model of colitis-associated cancer, Methods Mol. Biol., 1422, 297, 10.1007/978-1-4939-3603-8_26 Neufert, 2007, An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression, Nat. Protoc., 2, 1998, 10.1038/nprot.2007.279 Derdak, 2013, Inhibition of p53 attenuates steatosis and liver injury in a mouse model of non-alcoholic fatty liver disease, J. Hepatol., 58, 785, 10.1016/j.jhep.2012.11.042 Koelzer, 2015, Phenotyping of tumor-associated macrophages in colorectal cancer: impact on single cell invasion (tumor budding) and clinicopathological outcome, OncoImmunology, 5 Snodgrass, 2013, Inflammasome-mediated secretion of IL-1β in human monocytes through TLR2 activation; modulation by dietary fatty acids, J. Immunol., 191, 4337, 10.4049/jimmunol.1300298 Shirasuna, 2016, Palmitic acid induces interleukin-1β secretion via NLRP3 inflammasomes and inflammatory responses through ROS production in human placental cells, J. Reprod. Immunol., 116, 104, 10.1016/j.jri.2016.06.001 Moon, 2016, NOX4-dependent fatty acid oxidation promotes NLRP3 inflammasome activation in macrophages, Nat. Med., 22, 1002, 10.1038/nm.4153 Zhang, 2018, Fatty acid oxidation contributes to IL-1β secretion in M2 macrophages and promotes macrophage-mediated tumor cell migration, Mol. Immunol., 94, 27, 10.1016/j.molimm.2017.12.011 Kalucka, 2018, Quiescent endothelial cells upregulate fatty acid β-oxidation for vasculoprotection via redox homeostasis, Cell Metabol., 28, 881, 10.1016/j.cmet.2018.07.016 Paik, 1970, Nonenzymatic acetylation of histones with acetyl-CoA, Biochim. Biophys. Acta Nucleic Acids Protein Synth., 213, 513, 10.1016/0005-2787(70)90058-4 Misawa, 2015, Resveratrol inhibits the acetylated α-tubulin-mediated assembly of the NLRP3-inflammasome, Int. Immunol., 27, 425, 10.1093/intimm/dxv018 Lewis, 1987, Inflammation, oxidative DNA damage, and carcinogenesis, Environ. Health Perspect., 76, 19, 10.1289/ehp.877619 Kühl, 2015, Diversity of intestinal macrophages in inflammatory bowel, Front. Immunol., 6, 613, 10.3389/fimmu.2015.00613 Zhang, 2017, Suppression colitis and colitis-associated colon cancer by anti-S100a9 antibody in mice, Front. Immunol., 8, 1774, 10.3389/fimmu.2017.01774 Castro-Dopico, 2019, Anti-commensal IgG drives intestinal inflammation and type 17 immunity in ulcerative colitis, Immunity, 50, 1099, 10.1016/j.immuni.2019.02.006 Ryzhakov, 2018, Alpha kinase 1 controls intestinal inflammation by suppressing the IL-12/Th1 axis, Nat. Commun., 9, 3797, 10.1038/s41467-018-06085-5 Chan, 2020, Inflammasome signaling and regulation of interleukin-family cytokines, J. Exp. Med., 217, 10.1084/jem.20190314 Swanson, 2019, The NLRP3 inflammasome: molecular activation and regulation to therapeutics, Nat. Rev. Immunol., 19, 477, 10.1038/s41577-019-0165-0 Evavold, 2019, Inflammasomes: threat-assessment organelles of the innate immune system, Immunity, 51, 609, 10.1016/j.immuni.2019.08.005 Man, 2018, Inflammasomes in the gastrointestinal tract: infection, cancer and gut microbiota homeostasis, Nat. Rev. Gastroenterol. Hepatol., 15, 721, 10.1038/s41575-018-0054-1 Pu, 2019, Systematic understanding of the mechanism and effects of Arctigenin attenuates inflammation in dextran sulfate sodium-induced acute colitis through suppression of NLRP3 inflammasome by SIRT1, Am. J. Tourism Res., 11, 3992‐4009 Ye, 2019, Tumor-infiltrating immune cells act as a marker for prognosis in colorectal cancer, Front. Immunol., 10, 2368, 10.3389/fimmu.2019.02368 Kelley, 2019, The NLRP3 inflammasome: an overview of mechanisms of activation and regulation, Int. J. Mol. Sci., 20, 3328, 10.3390/ijms20133328 Arbore, 2016, A novel “complement-metabolism-inflammasome axis” as a key regulator of immune cell effector function, Eur. J. Immunol., 44, 1563, 10.1002/eji.201546131 Hughes, 2018, Metabolic regulation of NLRP3, Immunol. Rev., 281, 88, 10.1111/imr.12608 Moon, 2015, UCP2-induced fatty acid synthase promotes NLRP3 inflammasome activation during sepsis, J. Clin. Invest., 125, 665, 10.1172/JCI78253 Misawa, 2013, Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome, Nat. Immunol., 14, 454, 10.1038/ni.2550 Qu, 2016, Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer, Cell Death Dis., 19, e2226, 10.1038/cddis.2016.132